GL1X · GenesisL1 explorer

Research workbench

Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT103

Analyse Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT103 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6NRF
Type
protein
Length
240 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2
Source
Homo sapiens
Molecule
Poly [ADP-ribose] polymerase 1
EC
2.4.2.30, 2.4.2.-
UniProt
P09874
Ligands
KYV, CL
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · resolution 2 · 1 distinct chain · 26% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 1 (EC 2.4.2.30, 2.4.2.-)protein24026% helix, 35% strandP09874

Ligands and binding sites

  • KYV · 2-({4-[4-(1H-benzimidazol-2-yl)piperazine-1-carbonyl]phenyl}methyl)-3-hydroxy-1-benzofuran-7-carboxamide · ligand · chains A
  • CL · Chloride ion · ion · 2 copies · chains A
  • CIT · Citric acid · additive · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12270.580.8027DMS, KYV

Compared structures

  • 6NRF · Crystal structure of human parp-1 art domain bound to inhibitor UTT103 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.